Ofer Goldberg - Clal Biotechnology Insider

CBI -- Israel Stock  

ILS 341.80  0.90  0.26%

  VP
Mr. Ofer Goldberg serves as Vice President at Clal Biotechnology Industries Ltd. since September 1, 2003. Previously, Mr. Goldberg served as Director for BioCancell Therapeutics Inc from May 17, 2007 to October 21, 2009
Age: 42  VP Since 2003      
972 3 612 1616  http://www.cbi.co.il
Goldberg has a Bachelors degree in Mathematics and Physics from The Hebrew University of Jerusalem and a Masters degree in Finance and Economics from the TelAviv University.

Management Efficiency

The company has return on total asset (ROA) of (4.59) % which means that it has lost $4.59 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (2.14) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 85.39 M in total debt with debt to equity ratio (D/E) of 10.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Clal Biotechnology Industries Ltd has Current Ratio of 3.35 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 2 records

VP Since

Liliana BarKamada Ltd
2012
Pnina StraussKamada Ltd
2015

Entity Summary

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. Clal Biotechnology operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange.Clal Biotechnology Industries Ltd (CBI) is traded on Tel Aviv Stock Exchange in Israel. It is located in Azrieli Center and employs 14 people.

Clal Biotechnology Leadership Team

Ofer Goldberg, VP
Sigalia Heifetz, Director
Shmuel Rubinstein, External Director
Tomer Babai, Director
Dafna Gruber, Director
Aharon Schwartz, Director
Gavriel Barabash, Director
Isaac Kohlberg, Director
Nofar Malovani, Director
Assaf Segal, CFO
Ofer Gonen, Vice President
Avraham Fischer, Chairman of the Board
Yuval Yanai, External Director
Julian Adams, President Chief Scientific Officer
Orit Lidor, VP and General Counsel

Stock Performance Indicators

Did you try this?

Run Cryptocurrency Arbitrage Now

   

Cryptocurrency Arbitrage

Find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage
All  Next Launch Cryptocurrency Arbitrage

Clal Biotechnology Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Clal Biotechnology and Kamada Ltd. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.
Search macroaxis.com